ArticleFrontiers in oncology2022

Inhibition of Angiogenesis and Extracellular Matrix Remodeling: Synergistic Effect of Renin-Angiotensin System Inhibitors and Bevacizumab.

Tianshu Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.